ANAPTYSBIO INC (ANAB) Forecast, Price Target & Analyst Ratings

NASDAQ:ANAB • US0327241065

Current stock price

65.54 USD
+3.41 (+5.49%)
At close:
65.05 USD
-0.49 (-0.75%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ANAPTYSBIO INC (ANAB).

Forecast Snapshot

Consensus Price Target

Price Target
$79.82
+ 21.78% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.96
Revenue Estimate
29.123M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.26%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$79.82
Upside
+ 21.78%
From current price of $65.54 to mean target of $79.82, Based on 19 analyst forecasts
Low
$50.50
Median
$76.50
High
$147.00

Price Target Revisions

1 Month
21.16%
3 Months
37.28%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for ANAB. The average price target is 79.82 USD. This implies a price increase of 21.78% is expected in the next year compared to the current price of 65.54.
The average price target has been revised upward by 37.28% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ANAB Current Analyst RatingANAB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

ANAB Historical Analyst RatingsANAB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
85.26%
ANAB was analyzed by 19 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ANAB.
In the previous month the buy percentage consensus was at a similar level.
ANAB was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-31Piper SandlerMaintains Overweight -> Overweight
2026-03-30HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-17UBSMaintains Buy -> Buy
2026-03-12WedbushMaintains Outperform -> Outperform
2026-03-09Truist SecuritiesMaintains Hold -> Hold
2026-03-05StifelMaintains Buy -> Buy
2026-03-04BarclaysMaintains Overweight -> Overweight
2026-03-04HC Wainwright & Co.Maintains Buy -> Buy
2026-01-20BarclaysMaintains Overweight -> Overweight
2025-12-17BarclaysMaintains Overweight -> Overweight
2025-12-11StifelMaintains Buy -> Buy
2025-11-24WedbushReiterate Outperform -> Outperform
2025-11-24HC Wainwright & Co.Maintains Buy -> Buy
2025-11-11BarclaysMaintains Overweight -> Overweight
2025-11-11HC Wainwright & Co.Maintains Buy -> Buy
2025-11-10Truist SecuritiesMaintains Hold -> Hold
2025-11-05GuggenheimMaintains Buy -> Buy
2025-11-05Wells FargoMaintains Overweight -> Overweight
2025-10-29StifelMaintains Buy -> Buy
2025-10-15WedbushMaintains Outperform -> Outperform
2025-10-13BarclaysInitiate Overweight
2025-09-30WedbushReiterate Outperform -> Outperform
2025-09-30HC Wainwright & Co.Maintains Buy -> Buy
2025-08-12UBSMaintains Neutral -> Neutral
2025-08-07WedbushMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.96
Revenue Estimate
29.123M
Revenue Q2Q
4.87%
EPS Q2Q
24.78%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
7.56%
Revenue (3 Months)
6.14%
EPS (1 Month)
10.27%
EPS (3 Months)
12.07%

Next Earnings Summary

ANAB is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.96 USD and the consensus revenue estimate is 29.12M USD.
The next earnings revenue estimate has been revised upward by 6.14% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ANAB revenue by date.ANAB revenue by date.
17.157M
66.73%		91.28M
432.03%		234.603M
157.01%		138.3M
-41.05%		181.32M
31.11%		264.21M
45.71%		326.32M
23.51%		499.22M
52.98%		709.19M
42.06%		881.18M
24.25%		1.129B
28.12%
EBITDA
YoY % growth
ANAB ebitda by date.ANAB ebitda by date.
-156.42M
-36.65%		-114.343M
26.90%		48.455M
142.38%		-5.355M
-111.05%		20.227M
477.72%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ANAB ebit by date.ANAB ebit by date.
-157.072M
-36.41%		-114.949M
26.82%		47.896M
141.67%		-84.512M
-276.45%		-129.86M
-53.66%		-55.227M
57.47%		-77.496M
-40.32%		103.17M
233.13%		350.37M
239.60%		507.24M
44.77%		785.73M
54.90%
Operating Margin
ANAB operating margin by date.ANAB operating margin by date.
-915.50%-125.93%20.42%-61.11%-71.62%-20.90%-23.75%20.67%49.40%57.56%69.60%
EPS
YoY % growth
ANAB eps by date.ANAB eps by date.
-6.08
-33.04%		-5.21
14.31%		-0.52
90.02%		-4.67
-797.23%		-5.50
-17.85%		-3.18
42.07%		-1.83
42.67%		3.86
311.17%		7.69
99.47%		10.89
41.64%		15.24
39.89%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.96
24.78%		-0.96
28.02%		-1.08
-308.17%		-1.20
-175.79%		-0.98
-1.32%		-0.93
3.63%		-0.89
17.61%		-0.68
43.10%
Revenue
Q2Q % growth		29.123M
4.87%		27.727M
24.54%		31.386M
-58.88%		36.391M
-66.38%		29.733M
2.09%		34.323M
23.79%		39.423M
25.61%		45.329M
24.56%
EBITDA
Q2Q % growth		-18.38M
32.90%		-17.646M
31.82%		-14.729M
-141.92%		4.294M
-93.63%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-20.371M
26.03%		-20.317M
22.36%		-21.589M
-162.21%		-26.704M
-139.92%		-26.668M
-30.91%		-24.917M
-22.64%		-23.065M
-6.84%		-12.507M
53.17%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ANAB Yearly Revenue VS EstimatesANAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
ANAB Yearly EPS VS EstimatesANAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-82.96%
EPS Next 5 Year
56.59%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
7.12%
Revenue Next 5 Year
18.35%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ANAPTYSBIO INC / ANAB Forecast FAQ

What is the price target for ANAB stock?

19 analysts have analysed ANAB and the average price target is 79.82 USD. This implies a price increase of 21.78% is expected in the next year compared to the current price of 65.54.

Can you provide the upcoming earnings date for ANAPTYSBIO INC?

ANAPTYSBIO INC (ANAB) will report earnings on 2026-05-04, after the market close.

What are the consensus estimates for ANAPTYSBIO INC (ANAB) next earnings?

The consensus EPS estimate for the next earnings of ANAPTYSBIO INC (ANAB) is -0.96 USD and the consensus revenue estimate is 29.12M USD.

What is the consensus rating for ANAB stock?

The consensus rating for ANAPTYSBIO INC (ANAB) is 85.2632 / 100 . This indicates that analysts generally have a positive outlook on the stock.